TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/26/2026
Back to search
Official data from USPTO
XP PHARMA CONSULTING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/27/2026
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
09/05/2024
Registration date
08/05/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/24/2024
First use in commerce
02/24/2024
Drawing code
5
Owner type
16
Owner location
Easton, PA
Examiner
SNAPP, TINA LOUISE
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized lettering XP in which the "X' is light blue and the "P" is dark blue. Underneath this lettering is the word PHARMA depicted in thick dark blue letters, and underneath this wording is the term CONSULTING depicted in smaller light blue letters. The mark is depicted on a white background.
Holders and representatives
Holders
XP Pharma Consulting, LLC
XP Pharma Consulting, LLC
Representatives
XP Pharma Consulting, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
24 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/26/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/26/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/17/2025
PUBO
PUBLISHED FOR OPPOSITION
06/17/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2025
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
04/16/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/16/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/15/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/15/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/15/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2025
GNRT
NON-FINAL ACTION E-MAILED
04/01/2025
CNRT
NON-FINAL ACTION WRITTEN
04/01/2025
DOCK
ASSIGNED TO EXAMINER
03/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/15/2025
NWAP
NEW APPLICATION ENTERED
09/05/2024
Continuous trademark protection
Get notified about every new filing that threatens XP PHARMA CONSULTING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.